Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Mahsa Owji"'
Autor:
Saeideh Salehizadeh, Roghayeh Saeidi, Mohammad Ali Sahraian, Hossein Rezaei Aliabadi, Seyedeh Nafiseh Hashemi, Sharareh Sharareh, Mohammad Reza Gheini, Shaghayegh Shahmirzaei, Mahsa Owji, Abdorreza Naser Moghadasi
Publikováno v:
Caspian Journal of Internal Medicine, Vol 13, Iss 3, Pp 484-489 (2022)
Background: The present study aimed to address the effect of Rituximab on the cognitive impairment in patients with secondary progressive MS (SPMS). Methods: The present interventional study used a convenience sampling method to select the study part
Externí odkaz:
https://doaj.org/article/4e09f82aaedc48d79e1a8e5a92458477
Publikováno v:
Caspian Journal of Internal Medicine, Vol 13, Iss Covid 19 Supplement 2, Pp 259-263 (2022)
Background: Coronavirus disease 2019 (COVID-19) involves different organs and clinical presentations varying from respiratory symptoms to gastrointestinal symptoms and neurological symptoms. Another group of symptoms are psychiatric symptoms and acco
Externí odkaz:
https://doaj.org/article/fa5b43b769f94417a44965a3ea70dc5d
Autor:
Fardin Nabizadeh, Mohammad Balabandian, Mohammad Reza Rostami, Mahsa Owji, Mohammad Ali Sahraian, Maryam Bidadian, Fereshteh Ghadiri, Nasim Rezaeimanesh, Abdorreza Naser Moghadasi
Publikováno v:
Current Journal of Neurology.
Background: Cognitive impairments in patients with multiple sclerosis (MS) are suggested as a prognostic factor for disease development, and consequently higher disability and more deficits in daily and social activities. In this regard, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfb10fe99e1b89b10752fb469aba59e4
https://doi.org/10.18502/cjn.v21i3.11106
https://doi.org/10.18502/cjn.v21i3.11106
Autor:
Fariba Askari, Mahsa Ghajarzadeh, Mehdi Mohammadifar, Amirreza Azimi, Mohammad Ali Sahraian, Mahsa Owji
Publikováno v:
Acta Medica Iranica, Vol 52, Iss 12 (2014)
The aim of the current study was to evaluate anxiety in patients with multiple sclerosis (MS) and factors which are associated with this symptom. Eighty totals of 180 patients with MS were enrolled in this cross-sectional study. They were asked to an
Externí odkaz:
https://doaj.org/article/b4af8acdd0cd420eb05373031e96b8ce
Autor:
Mahsa Ghajarzadeh, Mahsa Owji, Mohammad Ali Sauraian, Abdorreza Naser Moghadasi, Amirreza Azimi
Publikováno v:
Iranian Journal of Public Health, Vol 43, Iss 11 (2014)
Multiple sclerosis (MS) is an autoimmune disease that affects physical and emotional aspects of patient's lives. The aim of this study was to evaluate Emotional Intelligence (EI) in cases with MS.One hundred sixty six clinically definite MS and 110 h
Externí odkaz:
https://doaj.org/article/27ec03b535044ef8a1fc2227feb7c41d
Publikováno v:
Iranian Journal of Public Health, Vol 43, Iss 5 (2014)
Externí odkaz:
https://doaj.org/article/93724b40214d412180c4588fdad22f2f
Autor:
Saeideh, Salehizadeh, Roghayyeh, Saeedi, Mohammad Ali, Sahraian, Hossein, Rezaei Aliabadi, Seyedeh Nafiseh, Hashemi, Sharareh, Eskandarieh, Mohammad Reza, Gheini, Shaghayegh, Shahmirzaei, Mahsa, Owji, Abdorreza, Naser Moghadasi
Publikováno v:
Caspian journal of internal medicine. 13(3)
The present study aimed to address the effect of Rituximab on the cognitive impairment in patients with secondary progressive MS (SPMS).The present interventional study used a convenience sampling method to select the study participants from SPMS pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::220f5c87dd1764b000474a4f5b7fa7d1
https://pubmed.ncbi.nlm.nih.gov/35974939
https://pubmed.ncbi.nlm.nih.gov/35974939
Autor:
Mahsa Owji, Mohammad Alirezaei, Mohammad Ali Sahraian, Pourya Yarahmadi, Fereshteh Ghadiri, Abdorreza Naser Moghadasi, Seyed Mohammad Forouzannia, Maryam Bidadian
Publikováno v:
Multiple sclerosis and related disorders. 49
Background: One of the most concerning features that involves 40-70% of patients with multiple sclerosis (MS) is cognitive impairment. Moreover, it affects various aspects of patients’ life. In this regard, this study was conducted to find independ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31df861ba7ae1fb482a7d91315ce14c1
https://pubmed.ncbi.nlm.nih.gov/33567391
https://pubmed.ncbi.nlm.nih.gov/33567391
Autor:
Ali Shakouri Rad, Mohammad Ali Sahraian, Rozita Doosti, Amir Pejman Hashemi Taheri, Mahsa Owji, Masih Falahatian, Tina Roostaei, Abdorreza Naser Moghadasi, Esmaeil Mohamadi, Aria Nazeri, Nina Javadian, Rahil Mashhadi, Shokufeh Sadaghiani, Arash Nazeri, Aristotle N. Voineskos, Amirreza Azimi
Publikováno v:
Multiple Sclerosis Journal. 25:532-540
Background: Complement system activation products are present in areas of neuroinflammation, demyelination, and neurodegeneration in brains of patients with multiple sclerosis (MS). C3 is a central element in the activation of complement cascades. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16139360769524d7d8dfcbf0f32b24db
https://doi.org/10.1177/1352458518760715
https://doi.org/10.1177/1352458518760715
Autor:
Amir Ashraf-Ganjouei, Fereshteh Ghadiri, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi, Mahsa Owji, Maryam Bidadian
Publikováno v:
Multiple sclerosis and related disorders. 32
Background Many patients with multiple sclerosis (MS) endure cognitive impairment, which affects their everyday life and lowers their life quality. It has been demonstrated that obesity can result in poor cognitive performance in healthy individuals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98838f9ef7e946d3d9eab6a6d97f3f9f
https://pubmed.ncbi.nlm.nih.gov/31030017
https://pubmed.ncbi.nlm.nih.gov/31030017